US Stock MarketDetailed Quotes

Atara Biotherapeutics (ATRA)

Watchlist
  • 5.010
  • +0.110+2.24%
Close Apr 24 16:00 ET
  • 5.010
  • 0.0000.00%
Post 16:10 ET
40.97MMarket Cap1.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atara Biotherapeutics (ATRA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.87%-50.94M
76.72%-5.7M
-145.35%-9.79M
31.25%-7.32M
4.98%-28.14M
64.39%-68.72M
51.45%-24.47M
92.23%-3.99M
79.84%-10.65M
22.94%-29.61M
Net income from continuing operations
138.28%32.69M
73.17%-3.41M
80.36%-4.3M
112.53%2.39M
219.71%38.01M
69.07%-85.4M
79.00%-12.69M
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
Depreciation and amortization
-58.11%2.12M
-95.55%49K
-97.07%36K
-82.26%236K
29.04%1.8M
4.60%5.05M
-8.71%1.1M
1.74%1.23M
10.74%1.33M
14.58%1.39M
Other non cash items
-69.37%4.85M
-150.55%-1.97M
-67.71%1.22M
-99.27%30K
37.65%5.57M
-5.76%15.83M
-4.56%3.89M
-13.31%3.76M
-2.11%4.13M
-2.76%4.05M
Change In working capital
-238.30%-104.74M
91.19%-1.97M
-220.04%-7.88M
-277.51%-12.77M
-599.85%-82.11M
-301.81%-30.96M
-207.89%-22.41M
232.76%6.56M
-409.23%-3.38M
-160.01%-11.73M
-Change in receivables
-99.30%229K
548.98%660K
-275.99%-1.91M
-73.44%8.88M
-328.33%-7.39M
433.72%32.63M
99.57%-147K
215.99%1.09M
30,474.55%33.41M
-104.33%-1.73M
-Change in inventory
340.30%10.66M
--0
--0
--0
267.06%10.66M
45.39%-4.43M
94.86%-160K
275.51%4.77M
-5.71%-2.67M
-69.90%-6.38M
-Change in payables and accrued expense
-28.17%-17.46M
-142.24%-1.25M
-244.42%-2.1M
70.44%-2.94M
-38.39%-11.17M
-5.34%-13.62M
135.31%2.95M
-80.81%1.45M
-3,454.64%-9.95M
31.91%-8.07M
-Change in other current assets
612.00%6.19M
-86.29%299K
91.38%-321K
-14.88%1.66M
380.78%4.54M
-191.79%-1.21M
323.50%2.18M
-602.16%-3.73M
-30.15%1.96M
40.95%-1.62M
-Change in other current liabilities
58.50%-9.97M
74.75%-1.39M
48.11%-2.95M
42.43%-5.99M
115.11%365K
-1,579.51%-24.02M
-170.86%-5.51M
4.87%-5.69M
-728.12%-10.41M
50.56%-2.42M
-Change in other working capital
-364.84%-94.38M
98.64%-295K
-106.88%-596K
8.57%-14.38M
-1,033.11%-79.11M
-166.80%-20.3M
-172.76%-21.72M
538.96%8.67M
-3,386.47%-15.72M
185.94%8.48M
Cash from discontinued investing activities
Operating cash flow
25.87%-50.94M
76.72%-5.7M
-145.35%-9.79M
31.25%-7.32M
4.98%-28.14M
64.39%-68.72M
51.45%-24.47M
92.23%-3.99M
79.84%-10.65M
22.94%-29.61M
Investing cash flow
Cash flow from continuing investing activities
110.44%18.15M
150.00%8.44M
85.47%-2.42M
-170.46%-5.07M
16.86%17.2M
-93.04%8.62M
-66.05%3.38M
-123.66%-16.67M
-85.46%7.2M
345.00%14.72M
Net PPE purchase and sale
485.37%948K
716.67%555K
--44K
1,303.45%349K
--0
79.47%-246K
-104.55%-90K
--0
94.19%-29K
68.17%-127K
Net investment purchase and sale
93.91%17.2M
127.50%7.89M
85.21%-2.47M
-175.00%-5.42M
15.86%17.2M
-92.91%8.87M
-65.30%3.47M
-123.57%-16.67M
-85.54%7.23M
364.69%14.84M
Cash from discontinued investing activities
Investing cash flow
110.44%18.15M
150.00%8.44M
85.47%-2.42M
-170.46%-5.07M
16.86%17.2M
-93.04%8.62M
-66.05%3.38M
-123.66%-16.67M
-85.46%7.2M
345.00%14.72M
Financing cash flow
Cash flow from continuing financing activities
-72.85%16.1M
99.09%-3K
-97.07%1.05M
4,823.46%15.3M
-101.04%-250K
2,849.35%59.28M
-121.69%-328K
17,308.17%35.79M
-168.79%-324K
10,172.77%24.14M
Net issuance payments of debt
71.97%-250K
--0
--0
--0
-10.13%-250K
5.81%-892K
-9.30%-235K
5.29%-197K
-9.91%-233K
27.24%-227K
Net common stock issuance
-72.79%16.31M
88.10%-25K
-67.84%16.34M
--0
--0
2,706.69%59.95M
-113.58%-210K
--50.81M
-29,952.00%-15.03M
3,708.44%24.37M
Proceeds from stock option exercised by employees
-84.78%35K
-81.20%22K
--12K
----
----
-75.22%230K
-35.36%117K
--0
-84.87%113K
--0
Net other financing activities
85.71%-1K
--0
--0
----
----
93.46%-7K
--0
--0
92.86%-1K
93.55%-6K
Cash from discontinued financing activities
Financing cash flow
-72.85%16.1M
99.09%-3K
-97.07%1.05M
4,823.46%15.3M
-101.04%-250K
2,849.35%59.28M
-121.69%-328K
17,308.17%35.79M
-168.79%-324K
10,172.77%24.14M
Net cash flow
Beginning cash position
-3.12%25.18M
-87.68%5.74M
-46.27%16.9M
-60.30%13.99M
-3.12%25.18M
-72.08%25.99M
-28.24%46.6M
-31.67%31.46M
-27.93%35.23M
-72.08%25.99M
Current changes in cash
-1,958.45%-16.69M
112.79%2.74M
-173.72%-11.16M
177.29%2.92M
-221.01%-11.19M
98.79%-811K
45.00%-21.42M
-19.87%15.14M
-32.71%-3.77M
120.92%9.25M
End cash Position
-66.31%8.48M
-66.31%8.48M
-87.68%5.74M
-46.27%16.9M
-60.30%13.99M
-3.12%25.18M
-3.12%25.18M
-28.24%46.6M
-31.67%31.46M
-27.93%35.23M
Free cash flow
26.13%-50.94M
76.80%-5.7M
-145.35%-9.79M
31.44%-7.32M
5.38%-28.14M
64.49%-68.96M
51.32%-24.56M
92.27%-3.99M
79.97%-10.67M
23.41%-29.74M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.87%-50.94M76.72%-5.7M-145.35%-9.79M31.25%-7.32M4.98%-28.14M64.39%-68.72M51.45%-24.47M92.23%-3.99M79.84%-10.65M22.94%-29.61M
Net income from continuing operations 138.28%32.69M73.17%-3.41M80.36%-4.3M112.53%2.39M219.71%38.01M69.07%-85.4M79.00%-12.69M68.61%-21.91M73.21%-19.05M57.53%-31.75M
Depreciation and amortization -58.11%2.12M-95.55%49K-97.07%36K-82.26%236K29.04%1.8M4.60%5.05M-8.71%1.1M1.74%1.23M10.74%1.33M14.58%1.39M
Other non cash items -69.37%4.85M-150.55%-1.97M-67.71%1.22M-99.27%30K37.65%5.57M-5.76%15.83M-4.56%3.89M-13.31%3.76M-2.11%4.13M-2.76%4.05M
Change In working capital -238.30%-104.74M91.19%-1.97M-220.04%-7.88M-277.51%-12.77M-599.85%-82.11M-301.81%-30.96M-207.89%-22.41M232.76%6.56M-409.23%-3.38M-160.01%-11.73M
-Change in receivables -99.30%229K548.98%660K-275.99%-1.91M-73.44%8.88M-328.33%-7.39M433.72%32.63M99.57%-147K215.99%1.09M30,474.55%33.41M-104.33%-1.73M
-Change in inventory 340.30%10.66M--0--0--0267.06%10.66M45.39%-4.43M94.86%-160K275.51%4.77M-5.71%-2.67M-69.90%-6.38M
-Change in payables and accrued expense -28.17%-17.46M-142.24%-1.25M-244.42%-2.1M70.44%-2.94M-38.39%-11.17M-5.34%-13.62M135.31%2.95M-80.81%1.45M-3,454.64%-9.95M31.91%-8.07M
-Change in other current assets 612.00%6.19M-86.29%299K91.38%-321K-14.88%1.66M380.78%4.54M-191.79%-1.21M323.50%2.18M-602.16%-3.73M-30.15%1.96M40.95%-1.62M
-Change in other current liabilities 58.50%-9.97M74.75%-1.39M48.11%-2.95M42.43%-5.99M115.11%365K-1,579.51%-24.02M-170.86%-5.51M4.87%-5.69M-728.12%-10.41M50.56%-2.42M
-Change in other working capital -364.84%-94.38M98.64%-295K-106.88%-596K8.57%-14.38M-1,033.11%-79.11M-166.80%-20.3M-172.76%-21.72M538.96%8.67M-3,386.47%-15.72M185.94%8.48M
Cash from discontinued investing activities
Operating cash flow 25.87%-50.94M76.72%-5.7M-145.35%-9.79M31.25%-7.32M4.98%-28.14M64.39%-68.72M51.45%-24.47M92.23%-3.99M79.84%-10.65M22.94%-29.61M
Investing cash flow
Cash flow from continuing investing activities 110.44%18.15M150.00%8.44M85.47%-2.42M-170.46%-5.07M16.86%17.2M-93.04%8.62M-66.05%3.38M-123.66%-16.67M-85.46%7.2M345.00%14.72M
Net PPE purchase and sale 485.37%948K716.67%555K--44K1,303.45%349K--079.47%-246K-104.55%-90K--094.19%-29K68.17%-127K
Net investment purchase and sale 93.91%17.2M127.50%7.89M85.21%-2.47M-175.00%-5.42M15.86%17.2M-92.91%8.87M-65.30%3.47M-123.57%-16.67M-85.54%7.23M364.69%14.84M
Cash from discontinued investing activities
Investing cash flow 110.44%18.15M150.00%8.44M85.47%-2.42M-170.46%-5.07M16.86%17.2M-93.04%8.62M-66.05%3.38M-123.66%-16.67M-85.46%7.2M345.00%14.72M
Financing cash flow
Cash flow from continuing financing activities -72.85%16.1M99.09%-3K-97.07%1.05M4,823.46%15.3M-101.04%-250K2,849.35%59.28M-121.69%-328K17,308.17%35.79M-168.79%-324K10,172.77%24.14M
Net issuance payments of debt 71.97%-250K--0--0--0-10.13%-250K5.81%-892K-9.30%-235K5.29%-197K-9.91%-233K27.24%-227K
Net common stock issuance -72.79%16.31M88.10%-25K-67.84%16.34M--0--02,706.69%59.95M-113.58%-210K--50.81M-29,952.00%-15.03M3,708.44%24.37M
Proceeds from stock option exercised by employees -84.78%35K-81.20%22K--12K---------75.22%230K-35.36%117K--0-84.87%113K--0
Net other financing activities 85.71%-1K--0--0--------93.46%-7K--0--092.86%-1K93.55%-6K
Cash from discontinued financing activities
Financing cash flow -72.85%16.1M99.09%-3K-97.07%1.05M4,823.46%15.3M-101.04%-250K2,849.35%59.28M-121.69%-328K17,308.17%35.79M-168.79%-324K10,172.77%24.14M
Net cash flow
Beginning cash position -3.12%25.18M-87.68%5.74M-46.27%16.9M-60.30%13.99M-3.12%25.18M-72.08%25.99M-28.24%46.6M-31.67%31.46M-27.93%35.23M-72.08%25.99M
Current changes in cash -1,958.45%-16.69M112.79%2.74M-173.72%-11.16M177.29%2.92M-221.01%-11.19M98.79%-811K45.00%-21.42M-19.87%15.14M-32.71%-3.77M120.92%9.25M
End cash Position -66.31%8.48M-66.31%8.48M-87.68%5.74M-46.27%16.9M-60.30%13.99M-3.12%25.18M-3.12%25.18M-28.24%46.6M-31.67%31.46M-27.93%35.23M
Free cash flow 26.13%-50.94M76.80%-5.7M-145.35%-9.79M31.44%-7.32M5.38%-28.14M64.49%-68.96M51.32%-24.56M92.27%-3.99M79.97%-10.67M23.41%-29.74M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -